Location History:
- San Francisco, CA (US) (2020 - 2023)
- Redwood City, CA (US) (2021 - 2023)
Company Filing History:
Years Active: 2020-2023
Title: Innovations of Chris Dong in Capsule Technology
Introduction
Chris Dong is an accomplished inventor based in San Francisco, CA. He has made significant contributions to the field of capsule technology, holding a total of five patents. His work focuses on developing innovative methods for manufacturing capsules that incorporate advanced digital sensors.
Latest Patents
One of Chris Dong's latest patents is titled "Methods for manufacturing capsules with ingestible event markers." This patent presents various methods and apparatuses for creating an ingestible capsule that includes a digital sensor component embedded within it. The ingestible sensor is designed to activate upon contact with conductive fluids, such as the stomach's fluids. Once activated, the sensor can perform multiple tasks, including transmitting signals and collecting biometric data from the individual who ingested the capsule. Another notable patent is for "Lisinopril compositions with an ingestible event marker." This patent provides compositions for the ingestible administration of lisinopril, which may include additional components such as silicon, magnesium metal, and copper (I) chloride.
Career Highlights
Chris Dong has worked with Otsuka Pharmaceutical Company, Limited, where he has contributed to the development of innovative pharmaceutical solutions. His experience in the industry has allowed him to refine his skills and focus on creating groundbreaking technologies in capsule manufacturing.
Collaborations
Throughout his career, Chris has collaborated with talented individuals such as Nikhil Pargaonkar and Kurt Scheinpflug. These collaborations have fostered a creative environment that has led to the development of his innovative patents.
Conclusion
Chris Dong's work in capsule technology exemplifies the spirit of innovation and dedication to improving healthcare solutions. His patents reflect a commitment to advancing the field and enhancing the capabilities of ingestible technologies.